# data[].attributes.attachment_link.title
PORTARIA GM_MS Nº 299, DE 22 DE MARÇO DE 2023 - PORTARIA GM_MS Nº 299, DE 22 DE MARÇO DE 2023 - DOU - Imprensa Nacional  CCU

# data[].attributes.attachment_link.readable_text
Da Agência Senado | 13/06/2024, 09h44

O presidente Luiz Inácio Lula da Silva sancionou com um veto a Lei 14.886, de 2024, que institui o Programa Nacional de Vacinação em Escolas Públicas. O plano tem como objetivo elevar a cobertura vacinal da população, especialmente entre os alunos da educação infantil e do ensino fundamental. O texto foi publicado na quarta-feira (12), em edição extra do Diário Oficial da União.

Lula vetou um artigo do projeto de lei (PL) 826/2019, aprovado em maio pelo Senado. O dispositivo dava prazo de cinco dias para a escola enviar à unidade de saúde a lista de alunos que não comparecessem à campanha vacinação. Os pais também seriam notificados e orientados a buscar o posto de saúde mais próximo. Para o Poder Executivo, a medida "ensejaria potencial conflito de competência" entre os profissionais das áreas de educação e saúde.

O que diz a lei

A Lei 14.886, de 2024, obriga todos os estabelecimentos que recebam recursos públicos a participar do Programa Nacional de Vacinação em Escolas Públicas. As escolas particulares também podem participar, caso manifestem interesse.

De acordo com o texto, o estabelecimento de ensino deve entrar em contato com a unidade de saúde mais próxima para informar a quantidade de alunos matriculados e agendar a data de vacinação. A escola deve comunicar as famílias, com pelo menos cinco dias de antecedência, a data de visita da equipe de saúde.

A vacinação nas escolas deve ocorrer após o início da Campanha Nacional de Vacinação contra a Influenza e contemplar vacinas de rotina e de campanhas. Se o aluno não tiver o cartão de vacinação, a unidade de saúde responsável deve fornecer um novo documento. Se houver disponibilidade de doses, os adultos da comunidade escolar também podem ser vacinados.

Tramitação

A Lei 14.886, de 2024, é resultado do PL 826/2019, da Câmara dos Deputados. No Senado, a matéria recebeu relatórios favoráveis dos senadores Humberto Costa (PT-PE), na Comissão de Assuntos Sociais, e Marcelo Castro (MDB-PI), na Comissão de Educação e no Plenário.
Agência Senado (Reprodução autorizada mediante citação da Agência Senado)

# data[].attributes.attachment_link.title
Lula sanciona Programa Nacional de Vacinação em Escolas Públicas

# data[].attributes.attachment_link.description
O presidente Luiz Inácio Lula da Silva sancionou com um veto a Lei 14.886, de 2024, que institui o Programa Nacional de Vacinação em Escolas Públicas. O plano tem como objetivo elevar a cobertura vacinal da população, especialmente entre os alunos da educação infantil e do ensino fundamental.

# data[].attributes.attachment_link.title
Ministério da Saúde adota esquema de vacinação em dose única contra o HPV

# data[].attributes.attachment_link.description
Estratégia busca intensificar proteção contra o câncer de colo de útero e outras complicações associadas ao vírus e permite dobrar a capacidade de imunização com o estoque atual da pasta

# data[].attributes.attachment_link.title
PORTARIA GM_MS Nº 3.681INSTITUI PNCP_ (1) destaque

# data[].attributes.attachment_link.title
LEI Nº 14.886, DE 11 DE JUNHO DE 2024 - LEI Nº 14.886, DE 11 DE JUNHO DE 2024 - DOU - Imprensa Nacional vacina naescola

# data[].attributes.headline
LEI Nº 14.758 DE 19 DE DEZEMBRO DE 2023 institui a Política Nacional de Prevenção e Controle do Câncer no âmbito do Sistema Único de Saúde (SUS) e o Programa Nacional de Navegação da Pessoa com Diagnóstico de Câncer; e altera a Lei nº 8.080, de 19 de setembro de 1990 (Lei Orgânica da Saúde).

# data[].attributes.subject
LEI Nº 14.758 DE 19 DE DEZEMBRO DE 2023 institui a Política Nacional de Prevenção e Controle do Câncer no âmbito do Sistema Único de Saúde (SUS) e o Programa Nacional de Navegação da Pessoa com Diagnóstico de Câncer; e altera a Lei nº 8.080, de 19 de setembro de 1990 (Lei Orgânica da Saúde).

# data[].attributes.attachment_link.description
Documents selected by the World Health Organization

# data[].attributes.attachment_link.readable_text
A global network for evidence-informed health policy-making

​The Evidence-informed Policy Network (EVIPNet) is a global initiative embracing cutting-edge approaches to knowledge translation for better health policy-making. ​

EVIPNet supports countries in leveraging the best available, actionable evidence to deliver high-quality and effective healthcare policies and sustainably strengthen national health systems. ​

Developed by the SUPporting POlicy relevant Reviews and Trials (SUPPORT), this tool provides questions to help decision-makers implement evidence-based policy in practice. English, Spanish, French and Portuguese versions of the tools available here.

Health Systems Evidence is a continuously updated repository of syntheses of research evidence about governance, financial and delivery arrangements within health systems, and about implementation strategies that can support change in health systems.

These guides are intended for those responsible for preparing and supporting the use of policy briefs and ensuring that decisions about health systems are well-informed by research evidence. Examples used are taken from policy briefs and address important problems in African countries.

Evidence-informed decision-making (EIDM) entails identifying, appraising, and mobilizing the best available evidence for safe and effective health policy...

World Health Organization Evidence Informed Policy Network
20, Avenue Appia
CH-1211 Geneva 27
Switzerland

Email: [email protected]

# data[].attributes.attachment_link.description
A global network for evidence-informed health policy-making ​The Evidence-informed Policy Network (EVIPNet) is a global initiative embracing cutting-edge approaches to knowledge translation for better health policy-making. ​ EVIPNet supports countries in leveraging the best available, actionable evidence to deliver high-quality and effective healthcare policies and sustainably strengthen national health systems. ​ Developed by the SUPporting POlicy relevant Reviews and Trials (SUPPORT), this tool provides questions to help decision-makers implement evidence-based policy in practice.

# data[].attributes.attachment_link.readable_text
Overview

This WHO checklist is for any organization or person supporting the routine use of evidence in the process of policy-making. Evidence-informed policy-making (EIPM) is essential for achieving the Sustainable Development Goals (SDGs) and universal health coverage (UHC). Its importance is emphasized in WHO's Thirteenth General Programme of Work 2019-2023 (GPW13). This checklist was developed by the WHO Secretariat of Evidence-Informed Policy Network (EVIPNet) to assist its Member countries in institutionalizing EIPM. Government agencies (i.e. the staff of the Ministry of Health), knowledge intermediaries and researchers focused on strengthening EIPM will find in this checklist some key steps and tools to help their work. While the health sector is a key target group for EVIPNet, this tool can be applied by stakeholders from different social sectors.

# data[].attributes.attachment_link.title
Supporting the routine use of evidence during the policy-making process: a WHO checklist

# data[].attributes.attachment_link.description
By routinely making use of evidence in policy-making, governments are likely to achieve more effective policy development for societal progress. This tool can be used (i) to bring awareness about the importance of evidence use, (ii) when a country is initiating activities towards institutionalizing evidence use in policies (i.e.

# data[].attributes.attachment_link.description
When autocomplete results are available use up and down arrows to review and enter to select.

# data[].attributes.attachment_link.readable_text
A test to detect human papillomavirus (HPV) in cervical samples was developed based on the evidence that persistent infection with certain HPV types was necessary for the development of nearly 95% of cervical cancers. There is now compelling evidence that HPV tests are superior to cervical cytology (Pap smear) or visual inspection of the cervix with acetic acid (VIA) in detecting cervical precancer and cancer; thus, they are the most suitable cervical screening test.

In November 2020, the World Health Organization (WHO) launched a global initiative to accelerate the elimination of cervical cancer as a public health problem worldwide. Elimination of this virus-induced cancer is feasible through vaccination against HPV, screening with HPV testing, and appropriate treatment of the screen-detected precancers and cancers. Prevention of cervical cancer will have a far-reaching global impact, given that more than 300 000 women per year still die from this cancer and that more than 80% of these deaths occur in low- and middle-income countries.

Modelling studies have shown that achievement of the following targets by all countries by 2030 will reduce cervical cancer incidence to fewer than 4 new cases per 100 000 women per year globally (from 13.3 new cases per 100 000 women in 2020) by 2100:

90% of girls are fully vaccinated with the HPV vaccine by the age of 15 years;

70% of women are screened using a high-performance test (e.g. HPV test) by the age of 35 years, and again by the age of 45 years;

90% of women diagnosed with cervical precancer or cancer receive appropriate treatment.

# data[].attributes.attachment_link.title
Using HPV tests for cervical cancer screening and managing HPV-positive women - a practical online guide

# data[].attributes.attachment_link.description
A test to detect human papillomavirus (HPV) in cervical samples was developed based on the evidence that persistent infection with certain HPV types was necessary for the development of nearly 95% of cervical cancers.

# data[].attributes.headline
MANUAL DE POLÍTICAS  E ESTRATÉGIAS PARA A QUALIDADE DOS CUIDADOS DE SAÚDE

# data[].attributes.subject
MANUAL DE POLÍTICAS  E ESTRATÉGIAS PARA A QUALIDADE DOS CUIDADOS DE SAÚDE

# data[].attributes.attachment_link.description
body { margin: 0; font-family: Arial, Helvetica, sans-serif; } .topnav { overflow: hidden; background-color: #DBDBDD; } .topnav a { float: left; color: black; text-align: center; padding: 14px 16px; text-decoration: none; font-size: 17px; font-weight: bold; } .topnav a:hover { background-color: #149AD6; color: white; } .topnav a.active { background-color: #149AD6; color: white; }

# data[].attributes.attachment_link.readable_text
Overview

The "WHO handbook for national quality policy and strategy" outlines an approach for the development of national policies and strategies to improve the quality of care. Such policy and strategy can help clarify the structures, roles and responsibilities within national quality efforts, support the institutionalization of a culture of quality, and secure buy-in from health system leaders and stakeholders.

The handbook is not a prescriptive process guide but is designed to support teams developing policies and strategies in this area, and very much recognizes the varied expertise, experience and resources available to countries. It outlines eight essential elements to be considered by teams developing national quality policy and strategy: national health goals and priorities; local definition of quality; stakeholder mapping and engagement; situational analysis; governance and organizational structure; improvement methods and interventions; health management information systems and data systems; quality indicators and core measures.

The NQPS handbook was co-developed with countries each finding themselves at different stages of the development and execution of national quality policies and strategies and was informed by the review of a sample of more than 20 existing quality strategies across low-, middle- and high-income countries globally.

# data[].attributes.attachment_link.title
Handbook for national quality policy and strategy: a practical approach for developing policy and strategy to improve quality of care

# data[].attributes.attachment_link.description
The "WHO handbook for national quality policy and strategy" outlines an approach for the development of national policies and strategies to improve the quality of care. Such policy and strategy can help clarify the structures, roles and responsibilities within national quality efforts, support the institutionalization of a culture of quality, and secure buy-in from health system leaders and stakeholders.

# data[].attributes.attachment_link.title
Virtual Course on Comprehensive Cervical Cancer Control in Latin America and the Caribbean

# data[].attributes.attachment_link.description
This course aims to improve the training of health providers in all aspects related to the prevention and control of cervical cancer, including its natural history, primary prevention through vaccination against HPV, detection and treatment of cervical lesions precancerous, diagnosis and treatment of invasive cervical cancer, and provision of palliative care.

# data[].attributes.attachment_link.description
O câncer do colo do útero, também chamado de câncer cervical, é causado pela infecção persistente por alguns tipos do Papilomavírus Humano - HPV (chamados de tipos oncogênicos). A infecção genital por esse vírus é muito frequente e na maioria das vezes não causa doença. Em alguns casos, ocorrem alte…